1. Home
  2. NXPL vs LGVN Comparison

NXPL vs LGVN Comparison

Compare NXPL & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextPlat Corp

NXPL

NextPlat Corp

HOLD

Current Price

$0.45

Market Cap

10.0M

ML Signal

HOLD

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$1.09

Market Cap

11.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXPL
LGVN
Founded
1997
2014
Country
United States
United States
Employees
180
N/A
Industry
Telecommunications Equipment
Medicinal Chemicals and Botanical Products
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
11.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NXPL
LGVN
Price
$0.45
$1.09
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
432.0K
8.6M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.76
EPS
N/A
N/A
Revenue
N/A
$709,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,183.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.48
52 Week High
$1.11
$1.83

Technical Indicators

Market Signals
Indicator
NXPL
LGVN
Relative Strength Index (RSI) 45.41 61.21
Support Level $0.41 $0.55
Resistance Level $0.69 $1.22
Average True Range (ATR) 0.07 0.13
MACD -0.01 0.00
Stochastic Oscillator 38.30 56.73

Price Performance

Historical Comparison
NXPL
LGVN

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: